//
Readmission and Mortality After Hospitalization for Myocardial Infarction and Heart Failure
Metformin Lowers Body Weight But Fails to Increase Insulin Sensitivity in Chronic Heart Failure Patients without Diabetes: a Randomized, Double-Blind, Placebo-Controlled Study
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial
Mechanical circulatory support devices in advanced heart failure: 2020 and beyond
Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors
Outcomes and Effect of Treatment According to Etiology in HFrEF An Analysis of PARADIGM-HF
Dilated cardiomyopathy: so many cardiomyopathies!
Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions